Abstract
Denying the elderly important advances in the treatment of lung cancer on prejudice alone is no longer justified. The fit elderly person with adequate organ function should be offered similar treatment to younger patients. Other elderly patients should ideally be included in randomised trials to provide an evidence base.
Original language | English |
---|---|
Pages (from-to) | 711-720 |
Number of pages | 9 |
Journal | Thorax |
Volume | 58 |
Issue number | 8 |
DOIs | |
Publication status | Published - 1 Aug 2003 |
Keywords
- Aged
- Aged, 80 and over
- diagnosis: Carcinoma, Non-Small-Cell Lung
- diagnosis: Carcinoma, Small Cell
- Humans
- diagnosis: Lung Neoplasms
- Neoplasm Staging
- Survival Analysis